Key Dates

Related Announcements

• September 26, 2023 - Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed). See NOFO PAR-23-302.

Issued by

National Institute of Mental Health (NIMH)

Purpose

The purpose of this Notice is to inform potential applicants of NIMH's participation, effective on and after June 5th, 2024 , in PAR-23-302, "Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)" and outline NIMH's area of interest.

The following text has been added to reflect NIMH's participation in this NOFO:

Part 1. Overview Information

Components of Participating Organizations

National Institute of Mental Health (NIMH)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.242

Part 2. Section I. Funding Opportunity Description

NIMH Area of Interest: The NIMH is specifically interested in the genetic architecture of mental illness and related traits.

Applicants should contact the scientific contacts at National Human Genome Research Institute and NIMH to determine which Institute is most appropriate for their application. 

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)
Jonathan Pevsner, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-728-5618
Email: jonathan.pevsner@nih.gov 

Financial/Grants Management Contact(s)

Heather Weiss
National Institute of Mental Health (NIMH)
Telephone: 301-443-4415
Email: weissh@mail.nih.gov

Inquiries

Please direct all inquiries to:

Jonathan Pevsner, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-728-5618
Email: jonathan.pevsner@nih.gov